IICT, a constituent lab of CSIR, and Lee Pharma, an integrated pharma company, based in ... - Latest Tweet by Prasar Bharati News Services
The latest Tweet by Prasar Bharati News Services states, 'IICT, a constituent lab of CSIR, and Lee Pharma, an integrated pharma company, based in Hyderabad have entered into a non-exclusive licensing agreement for the synthesis of 2-DG. 2-DG developed by DRDO and Dr. Reddy’s Lab. has received approval for use in Covid-19 patients'
IICT, a constituent lab of CSIR, and Lee Pharma, an integrated pharma company, based in Hyderabad have entered into a non-exclusive licensing agreement for the synthesis of 2-DG.
2-DG developed by DRDO and Dr. Reddy’s Lab. has received approval for use in Covid-19 patients pic.twitter.com/R4xaFfsJjR— Prasar Bharati News Services पी.बी.एन.एस. (@PBNS_India) June 9, 2021
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)
(The above story first appeared on LatestLY on Jun 09, 2021 05:36 PM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website latestly.com).
